US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 28, 2017 (9 years ago)

Nystatin and Triamcinolone Acetonide Cream

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability

What was recalled

Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distributed in a) 15 grams (NDC 51672-1263-1), b) 30 grams (NDC 51672-1263-2) and c) 60 grams (NDC 51672-1263-3) tubes, Rx only, TARO label; Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1 -- Dist. by: Taro Pharmaceuticals U.S.A. Inc., Hawthorne, NY 10532

Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
NDC code
51672-1263-1
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0676-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Triamcinolone recalls

See all
Class II · Moderate risk Ongoing

Testosterone 87.5mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0330-2026
Class II · Moderate risk Ongoing

Testosterone 200mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0329-2026
Class II · Moderate risk Ongoing

Testosterone 100mg

Reason Presence of Foreign substance - potential presence of metal particulate matter

F.H. INVESTMENTS, Inc. (dba Asteria Health) D-0328-2026
Class II · Moderate risk Ongoing

Tri-Moxi+¿

Reason Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC NDC 71384-746-06 D-0251-2026